Myomo enters $3M term loan with SVB; revises revolver Medicare concentration limit

MYOMO, INC.

New $3M term loan available until Feb 28, 2026; repayable in 36 monthly installments from Mar 1, 2026, maturing Feb 1, 2029.
Interest on term loan at greater of 5.0% or prime minus 1.0%; prepayment fee 1%-3% based on prepayment year.
Revolving line Medicare receivables concentration limit raised to 50% (from prior); German subsidiary deposit limit increased to $1.5M.
Existing $4M revolver (expandable to $5.5M) retains July 11, 2026 maturity; 8.5% floor or prime+0.5% interest.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.